{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:57:39Z","timestamp":1784750259861,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1245\/s10434-024-14960-3","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:03:50Z","timestamp":1706803430000},"page":"3437-3447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study"],"prefix":"10.1245","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-9377","authenticated-orcid":false,"given":"Keijiro","family":"Sugimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Sugase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Motoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Fujitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takushi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"issue":"2","key":"14960_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"14960_CR2","volume-title":"TMN classification of malignant tumors","author":"JDGM Brierley","year":"2017","unstructured":"Brierley JDGM, Wittekind C. TMN classification of malignant tumors. 8th edn. Oxford: Wiley-Blackwell; 2017.","edition":"8"},{"key":"14960_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-020-00785-y","volume":"18","author":"M Watanabe","year":"2021","unstructured":"Watanabe M, Tachimori Y, Oyama T, et al. Comprehensive registry of esophageal cancer in Japan, 2013. Esophagus. 2021;18:1\u201324.","journal-title":"Esophagus"},{"key":"14960_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-021-00879-1","volume":"19","author":"M Watanabe","year":"2022","unstructured":"Watanabe M, Toh Y, Ishihara R, et al. Comprehensive registry of esophageal cancer in Japan, 2014. Esophagus. 2022;19:1\u201326.","journal-title":"Esophagus"},{"key":"14960_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-022-00950-5","volume":"20","author":"M Watanabe","year":"2023","unstructured":"Watanabe M, Toh Y, Ishihara R, et al. Comprehensive registry of esophageal cancer in Japan, 2015. Esophagus. 2023;20:1\u201328.","journal-title":"Esophagus"},{"key":"14960_CR6","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0959-8049(97)00088-9","volume":"33","author":"H Bleiberg","year":"1997","unstructured":"Bleiberg H, Conroy T, Paillot B, et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer. 1997;33:1216\u201320.","journal-title":"Eur J Cancer"},{"key":"14960_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.annonc.2019.10.018","volume":"31","author":"M Moehler","year":"2020","unstructured":"Moehler M, Maderer A, Thuss-Patience PC, et al. Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO\/EORTC trial (POWER). Ann Oncol. 2020;31:228\u201335.","journal-title":"Ann Oncol"},{"key":"14960_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa2111380","volume":"386","author":"Y Doki","year":"2022","unstructured":"Doki Y, Ajani JA, Kato K, et al. Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. N Engl J Med. 2022;386:449\u201362.","journal-title":"N Engl J Med"},{"key":"14960_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(21)01234-4","volume":"398","author":"JM Sun","year":"2021","unstructured":"Sun JM, Shen L, Shah MA, et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet. 2021;398:759\u201371.","journal-title":"Lancet"},{"key":"14960_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","volume":"19","author":"K Yoshida","year":"2016","unstructured":"Yoshida K, Yamaguchi K, Okumura N, et al. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016;19:329\u201338.","journal-title":"Gastric Cancer"},{"key":"14960_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21037\/tgh.2016.05.12","volume":"1","author":"K Yamaguchi","year":"2016","unstructured":"Yamaguchi K, Yoshida K, Tanaka Y, et al. Conversion therapy for stage IV gastric cancer-the present and future. Transl Gastroenterol Hepatol. 2016;1:50.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"14960_CR12","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1245\/s10434-019-07727-8","volume":"26","author":"H Miyata","year":"2019","unstructured":"Miyata H, Sugimura K, Motoori M, et al. Clinical implications of conversion surgery after induction therapy for T4b thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2019;26:4737\u201343.","journal-title":"Ann Surg Oncol"},{"key":"14960_CR13","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1097\/SLA.0000000000004564","volume":"274","author":"K Sugimura","year":"2021","unstructured":"Sugimura K, Miyata H, Tanaka K, et al. Multicenter randomized phase 2 trial comparing chemoradiotherapy and docetaxel plus 5-fluorouracil and cisplatin chemotherapy as initial induction therapy for subsequent conversion surgery in patients with clinical T4b esophageal cancer: short-term results. Ann Surg. 2021;274:e465\u201372.","journal-title":"Ann Surg"},{"key":"14960_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/SLA.0000000000003557","volume":"272","author":"M Yano","year":"2020","unstructured":"Yano M, Sugimura K, Miyata H, et al. Randomized comparison of gastric tube reconstruction with and without duodenal diversion plus Roux-en-Y anastomosis after esophagectomy. Ann Surg. 2020;272:48\u201354.","journal-title":"Ann Surg"},{"key":"14960_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/SLA.0000000000000933","volume":"262","author":"H Miyata","year":"2014","unstructured":"Miyata H, Yamasaki M, Miyazaki Y, et al. Clinical importance of supraclavicular lymph node metastasis after neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg. 2014;262:280\u20135.","journal-title":"Ann Surg"},{"key":"14960_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11605-023-05615-x","volume":"27","author":"K Sugimura","year":"2023","unstructured":"Sugimura K, Miyata H, Kanemura T, et al. Patterns of recurrence and long-term survival of minimally invasive esophagectomy versus open esophagectomy for locally advanced esophageal cancer treated with neoadjuvant chemotherapy: a propensity score-matched analysis. J Gastrointest Surg. 2023;27:1055\u201365.","journal-title":"J Gastrointest Surg"},{"key":"14960_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/SLA.0000000000003445","volume":"273","author":"S Urakawa","year":"2021","unstructured":"Urakawa S, Makino T, Yamasaki M, et al. Lymph node response to neoadjuvant chemotherapy as an independent prognostic factor in metastatic esophageal cancer. Ann Surg. 2021;273:1141\u20139.","journal-title":"Ann Surg"},{"key":"14960_CR18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/SLA.0000000000004238","volume":"275","author":"T Hagi","year":"2022","unstructured":"Hagi T, Makino T, Yamasaki M, et al. Pathological regression of lymph nodes better predicts long-term survival in esophageal cancer patients undergoing neoadjuvant chemotherapy followed by surgery. Ann Surg. 2022;275:1121\u20139.","journal-title":"Ann Surg"},{"key":"14960_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"key":"14960_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-016-0551-7","volume":"14","author":"Esophageal S Japan","year":"2017","unstructured":"Japan Esophageal S. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14:1\u201336.","journal-title":"Esophagus"},{"key":"14960_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10388-016-0556-2","volume":"14","author":"Esophageal S Japan","year":"2017","unstructured":"Japan Esophageal S. Japanese classification of esophageal cancer, 11th edition: parts II and III. Esophagus. 2017;14:37\u201365.","journal-title":"Esophagus"},{"key":"14960_CR22","doi-asserted-by":"publisher","first-page":"doz034","DOI":"10.1093\/dote\/doz034","volume":"32","author":"MFJ Seesing","year":"2019","unstructured":"Seesing MFJ, van der Veen A, Brenkman HJF, et al. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study. Dis Esophagus. 2019;32:doz034.","journal-title":"Dis Esophagus"},{"key":"14960_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/00015458.2017.1411557","volume":"118","author":"E Van Daele","year":"2018","unstructured":"Van Daele E, Scuderi V, Pape E, et al. Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer. Acta Chir Belg. 2018;118:227\u201332.","journal-title":"Acta Chir Belg"},{"key":"14960_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/annonc\/mdw439","volume":"28","author":"M Yamasaki","year":"2017","unstructured":"Yamasaki M, Yasuda T, Yano M, et al. Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003). Ann Oncol. 2017;28:116\u201320.","journal-title":"Ann Oncol"},{"key":"14960_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ags3.12388","volume":"5","author":"K Sugimura","year":"2021","unstructured":"Sugimura K, Yamasaki M, Yasuda T, Yano M, Hirao M, Fujitani K, Kimura Y, et al. Long-term results of a randomized controlled trial comparing neoadjuvant adriamycin, cisplatin, and 5-fluorouracil (ACF) versus docetaxel, cisplatin, and 5-fluorouracil (DCF) followed by surgery for oesophageal cancer (OGSG1003). Ann Gastroenterol Surg. 2021;5:75\u201382.","journal-title":"Ann Gastroenterol Surg"},{"key":"14960_CR26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41416-022-01726-5","volume":"126","author":"T Makino","year":"2022","unstructured":"Makino T, Yamasaki M, Tanaka K, et al. Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma. Br J Cancer. 2022;126:1555\u201362.","journal-title":"Br J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14960-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-14960-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14960-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:06:05Z","timestamp":1712333165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-14960-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["14960"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-14960-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"There are no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The human ethics review committee of each institution approved the study protocol. Participants provided written informed consent. This study was performed in accordance with the Declarations of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Consent to participate"}},{"value":"All the authors have consented to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}